Literature DB >> 6092678

Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins.

T C Holland, F L Homa, S D Marlin, M Levine, J Glorioso.   

Abstract

A virus-neutralizing monoclonal antibody specific for glycoprotein C (gC) of herpes simplex virus type 1 strain KOS was used to select a number of neutralization-resistant mutants. A total of 103 of these mutants also were resistant to neutralization by a pool of gC-specific antibodies and thus were operationally defined as gC-. Analysis of mutant-infected cell mRNA showed that a 2.7-kilobase mRNA, comparable in size to the wild-type gC mRNA, was produced by nearly all mutants. However, six mutants, gC-5, gC-13, gC-21, gC-39, gC-46, and gC-98, did not produce the normal-size gC mRNA but rather synthesized a novel 1.1-kilobase RNA species. These mutants had deletions of 1.6 kilobases in the coding sequence of the gC structural gene, which explains their gC- phenotype. Despite the production of an apparently normal mRNA by the remaining 97 mutants, only 7 mutants produced a detectable gC polypeptide. In contrast to wild-type gC, which is a membrane-bound glycoprotein with an apparent molecular weight of 130,000 (130K), five of these mutants quantitatively secreted proteins of lower molecular weight into the culture medium. These were synLD70 (101K), gC-8 (109K), gC-49 (112K), gC-53 (108K), and gC-85 (106K). The mutant gC-3 secreted a protein that was indistinguishable in molecular weight from wild-type KOS gC. Another mutant, gC-44, produced a gC protein which also was indistinguishable from wild-type gC by molecular weight and which remained cell associated. Pulse-labeling of infected cells in the presence and absence of the glycosylation inhibitor tunicamycin demonstrated that these proteins were glycosylated and provided estimates of the molecular weights of the nonglycosylated primary translation products. The smallest of these proteins was produced by synLD70 and was 48K, about two-thirds the size of the wild-type polypeptide precursor (73K). Physical mapping of the mutations in synLD70 and gC-8 by marker rescue placed these mutations in the middle third of the gC coding sequence. Mapping of the mutations in other gC- mutants, including two in which no protein product was detected, also placed these mutations within or very close to the gC gene. The biochemical and genetic data available on mutants secreting gC gene products suggest that secretion is due to the lack of a functional transmembrane anchor sequence on these mutant glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092678      PMCID: PMC254559     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.

Authors:  P G Spear
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Proteins specified by herpes simplex virus. 3. Viruses differing in their effects on the social behavior of infected cells specify different membrane glycoproteins.

Authors:  J M Keller; P G Spear; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-04       Impact factor: 11.205

4.  Type-specific protein in herpes simplex virus envelope reacts with neutralising antibody.

Authors:  K L Powell; A Buchan; C Sim; D H Watson
Journal:  Nature       Date:  1974-05-24       Impact factor: 49.962

5.  Proteins specified by herpes simplex virus. VI. Viral proteins in the plasma membrane.

Authors:  J W Heine; P G Spear; B Roizman
Journal:  J Virol       Date:  1972-03       Impact factor: 5.103

6.  Magnesium precipitation of ribonucleoprotein complexes. Expedient techniques for the isolation of undergraded polysomes and messenger ribonucleic acid.

Authors:  R D Palmiter
Journal:  Biochemistry       Date:  1974-08-13       Impact factor: 3.162

7.  A procedure for the isolation of mammalian messenger ribonucleic acid.

Authors:  G Brawerman; J Mendecki; S Y Lee
Journal:  Biochemistry       Date:  1972-02-15       Impact factor: 3.162

8.  A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties.

Authors:  W E Rawls; D Laurel; J L Melnick; J M Glicksman; R H Kaufman
Journal:  Am J Epidemiol       Date:  1968-05       Impact factor: 4.897

9.  Evidence for the participation of saccharide-lipids in the synthesis of the oligosaccharide chain of ovalbumin.

Authors:  D K Struck; W J Lennarz
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

10.  Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains.

Authors:  J W Heine; R W Honess; E Cassai; B Roizman
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

View more
  59 in total

1.  The extracellular domain of herpes simplex virus gE is sufficient for accumulation at cell junctions but not for cell-to-cell spread.

Authors:  T Wisner; C Brunetti; K Dingwell; D C Johnson
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Analysis of the gB promoter of herpes simplex virus type 1: high-level expression requires both an 89-base-pair promoter fragment and a nontranslated leader sequence.

Authors:  N E Pederson; S Person; F L Homa
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Site-specific insertion of DNA into a pseudorabies virus vector.

Authors:  B Sauer; M Whealy; A Robbins; L Enquist
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity.

Authors:  B C Herold; D WuDunn; N Soltys; P G Spear
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

5.  Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.

Authors:  G Kümel; H C Kaerner; M Levine; C H Schröder; J C Glorioso
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

6.  Expression of glycoprotein gIII-human decay-accelerating factor chimera on the bovine herpesvirus 1 virion via a glycosyl phosphatidylinositol-based membrane anchor.

Authors:  X Liang; M Tang; T J Zamb; L A Babiuk; J Kowalski; M L Tykocinski
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

7.  Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C.

Authors:  C Seidel-Dugan; M Ponce de Leon; H M Friedman; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

8.  Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.

Authors:  P X Guo; S Goebel; S Davis; M E Perkus; B Languet; P Desmettre; G Allen; E Paoletti
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread.

Authors:  S Laquerre; R Argnani; D B Anderson; S Zucchini; R Manservigi; J C Glorioso
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.

Authors:  H P Huemer; Y Wang; P Garred; V Koistinen; S Oppermann
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.